Kaplan-Meier analyses also revealed that these features (i.e., tumor stage, PARP1, and FOXO3A) could predict prognostic outcomes of OS and RFS, respectively (log-rank test, P < 0.001, Figure 3B). Here, PARP1 is linked to neoplasm.